Mandate

Vinge advises Autoliv in public offer for AS Norma

March 05, 2010

Vinge is advising Autoliv in connection with its public offer for the remaining 49 percent of the shares in its part-owned Estonian subsidiary AS Norma. AS Norma is listed on NASDAQ OMX Tallinn. The offer is valued at approximately EUR 38 million.

The Vinge team includes partner Jan Byström and associate Petter Alberts.

Related

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025

Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund

Behold Ventures held its final closing on 27 June 2025, thereby securing investor commitments to its first-time fund amounting to approximately SEK 550 million from an international investor base, comprising the European Investment Fund (EIF), among others.
July 10, 2025